Google
BFRI — BIOFRONTERA INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
BFRI FAQ
What is BFRI's P/E ratio?
BIOFRONTERA INC (BFRI) currently trades at a P/E ratio of 2.34.
What is BFRI's ROE?
BIOFRONTERA INC reports a Return on Equity (ROE) of -182.62%.
What is BFRI's dividend yield?
BIOFRONTERA INC offers a dividend yield of 0.00%.
What is BFRI's Deepscope Quality Score?
Deepscope rates BFRI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BFRI?
Deepscope's AI Timing Score for BFRI is 62 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BFRI belong to?
BIOFRONTERA INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 1.00
Price
-0.06
(-6.03%)
Day Change
|
|
|---|
BFRI, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.00 |
| PBV / Sector |
2.17 / 2.65
|
| Earning Per Share | -0.84 |
| PE / Sector |
2.34 / 22.84
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.11
|
| Average 1M Daily Value |
0.21 M
GREAT
|
| Average 1W Daily Value |
0.19 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:12:40 |
| Symbol | BFRI |
| Name | BIOFRONTERA INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 12.80 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 13.19 / 9,638.91 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 660 Main Street, Woburn, MA, United States, 01801
Phone: 781 245 1325
Website: https://www.biofrontera-us.com
Employees: 84
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
